Biosimilars
Regularly updated material to support the introduction of aflibercept, golimumab, ranibizumab, ustekinumab and other biosimilars of interest.
Annual medicines planning
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.